Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial

Fig. 1

Flowchart of the trial. #MRI, questionnaires, and body composition will be acquired. ☩262 participants will be enrolled and equally allocated to the two groups (131 per group) in this trial; however, the number of participants actually enrolled may vary slightly. *The follow-up will be carried out at 3, 6, 12, and 24 months, with questionnaires and body composition being acquired at 3, 6, 12, and 24 months, hematological measurements being acquired at 6, 12, and 24 months, and MRI being acquired at 24 months

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us